Survey Finds German Medical Cannabis Patients Reduce Prescription Drug Use
German medical cannabis patients report reduced prescription drug use following cannabis initiation. This patient-reported outcome highlights significant clinical considerations. Careful monitoring and documentation are essential for safe medication…
Medical Cannabis Cuts Prescription Drug Use by 85%, German Patient Survey Finds
A German patient survey highlights prescription drug reduction medical cannabis effects, reporting an 85% decrease in prescription use. This finding has important implications for polypharmacy management and healthcare costs. However, the survey's…
Opioids and Cannabis: An Uncertain Combination?
This article examines opioid cannabis interactions, a critical topic as cannabis use rises among patients on opioids. Understanding these interactions is essential for safe pain management. Clinicians must monitor patients closely to mitigate risks…
Over 70% of MS Patients in Rehab Take 5+ Medications, Study Finds
Polypharmacy in MS rehabilitation is a significant clinical challenge, with over 70% of patients taking five or more medications. This study highlights the potential for cannabis to consolidate therapies and reduce drug interactions. Understanding…
High-tech Help: Cannabis Kiosks Aim to Simplify Access for Seniors
Cannabis kiosks for seniors aim to simplify access to cannabis products through user-friendly technology. This focus keyword highlights the importance of balancing ease of access with patient safety. Seniors face unique challenges including polypharmacy…
The A Block: Renaming a Phoenix High School and Cannabis Kiosks for Seniors
Cannabis accessibility initiatives for seniors require clinical oversight to ensure appropriate screening, dosing, and drug interaction management. Older adults have higher rates of polypharmacy and age-related physiological changes that significantly…
With Cannabis, Seniors Find Relief but Lack Clinical Oversight
Cannabis clinical oversight seniors require is critical for safe therapeutic use. Many older adults find relief with cannabis but face risks due to lack of medical supervision. Proper clinical oversight helps manage drug interactions and dosing in this…
Seniors and Cannabis: Understanding Drug Interactions and Market Trends
Cannabis drug interactions seniors face are critical to understand as over 25% of Delaware's adult-use cannabis market consists of seniors. This demographic shift highlights the need for awareness of polypharmacy risks and dosing considerations.…
Cannabis & Aging: An Evidence-Based Educational Workshop | Babylon Village, NY Patch
Geriatric cannabis use clinical considerations are essential due to age-related changes and polypharmacy risks. This workshop provides evidence-based education for safer cannabis use in older adults. Understanding these clinical factors helps bridge…